122
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The Value of ABO Blood Group and Complete Blood Count for the Prognosis Analysis of Gastric Cancer Patients

, & ORCID Icon
Pages 4627-4633 | Published online: 25 May 2020

References

  • Chen WQ, Zheng RS, BAADE PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
  • Weiwei G, Shenglan L, Ruying H, et al. Survival rate of gastric cancer in Zhejiang Province from 2005 to 2010. Chin J Oncol. 2014;36(8):636–639.
  • Peng P, Chunxiao W, Yangming G, et al. Study on the survival rate of gastric cancer in Shanghai population. Chin J Cancer. 2016;26(5):414–420.
  • Xiaolin C, Guoqiang Y, Jianrong L, et al. The value of preoperative peripheral blood NLR, d-NLR, PLR and LMR in prognostic diagnosis of patients with colorectal cancer. Chin J Immunol. 2015;10:1389–1393.
  • Jinlan H, Shihao Z, Qishui O, et al. Analysis of the value of preoperative peripheral blood NLR, dNLR and LMR in evaluating the prognosis of patients with glioblastoma. J Fujian Med Univ. 2017;51(6):404–409.
  • Huizi R, Xiping S. Study on the relationship between ABO blood group and 9 kinds of malignant tumors. Gansu Med. 2015;34(4):241–243.
  • Xiaojuan C, Jing W, Jing Y, et al. The value of abnormal prothrombin combined with CEA, CA72-4 and CA199 in the diagnosis and treatment of gastric cancer. Res Cancer Prev Treat. 2018;45(6):395–399.
  • Liya Z, Shiyu X. Research progress of Helicobacter pylori and gastric cancer. J Clin Intern Med. 2018;35(12):797–799.
  • Minfei P, Sufei Y, Jing W, et al. Wang Donglian. Study on the relationship between ABO blood group and the risk of 8 kinds of malignant tumors. Chin J Health Inspection. 2014;24(06):811–813,823.
  • Lingjun X, Jixiang Z. ABO blood group distribution and clinical characteristics of gastric cancer patients. Shandong Med. 2012;52(17):16–18.
  • Zhang A, Ning L, Han J, et al. Neutrophil-To-lymphocyte ratio as a potential biomarker of neovascular glaucoma. Ocul Immunol Inflamm. 2019;10:1–8. doi:10.1080/09273948.2019.1677916
  • Lin Y, Peng Y, Chen Y, et al. Association of lymphocyte to monocyte ratio and risk of in-hospital mortality in patients with acute type A aortic dissection. Biomark Med. 2019;13(15):1263–1272. doi:10.2217/bmm-2018-042331584289
  • Li KJ, Xia XF, Su M, et al. Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy. BMC Cancer. 2019;19(1):1004. doi:10.1186/s12885-019-6157-431655563
  • Song L, Zhu J, Li Z, et al. The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma. Cancer Manag Res. 2019;11:8451–8462. doi:10.2147/CMAR.S21916331572000
  • Jinping M, Zhi W, Jianwei L, et al. The application of neutrophil/lymphocyte ratio in the prognosis of gastric cancer. Chin J Gastrointest Surg. 2011;14(12):944–947.
  • Shumei L, Xiaoli X, Di L, et al. The prognostic value of peripheral blood neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with gastric cancer. Chin J Oncol. 2014;36(12):910–915.
  • Peng S, Zhao Y, Xin D, et al. The clinical significance of preoperative neutrophil to lymphocyte ratio (NLR) in predicting the prognosis of gastric cancer. Mod Oncol. 2012;20(5):987–991.
  • Qunhua D, Wei H, Zhen X, et al. Relationship between preoperative platelet distribution width and clinicopathological characteristics and prognosis in patients with gastric cancer. Chin Oncol Clin. 2018;45(2):72–76.
  • Li Q, Yu CH, Yu JH, et al. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. PLoS One. 2012;7:e29928. doi:10.1371/journal.pone.002992822235351
  • Wang DS, Chen DL, Ren C, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer. 2012;131:461–468. doi:10.1002/ijc.2637621858814
  • Poole EM, Gates MA, High BA, et al. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control. 2012;23:1805–1810. doi:10.1007/s10552-012-0059-y22961099
  • Wang DS, Wang ZQ, Zhang L, et al. Are risk factors associated with outcomes in pancreatic cancer. PLoS One. 2012;7:e41984. doi:10.1371/journal.pone.004198422911869
  • Wang Z, Liu L, Ji J, et al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci. 2012;13:13308–13321. doi:10.3390/ijms13101330823202954
  • Qiu MZ, Zhang DS, Ruan DY, et al. A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China. Med Oncol. 2011;28(Suppl 1):S268–73. doi:10.1007/s12032-010-9735-521053099
  • Xiao S, Feng F, Sun L, et al. Study on the relationship between ABO blood group and prognosis of patients with gastric cancer. Chin J Gastrointest Surg. 2015;18(10):1011–1015.
  • Kayser K, Hauck E, Andre S, et al. Expression of endogenous lectins (galectins, receptors for ABH-epitopes) and the MIB-1 antigen in esophageal carcinomas and their syntactic structure analysis in relation to post-surgical tumor stage and lymph node involvement. Anticancer Res. 2001;21:1439–1444.11396228
  • Barbalic M, Dupuis J, Dehghan A, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 2010;19:1863–1872. doi:10.1093/hmg/ddq06120167578